Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action

Autor: Euphemia Leung, Peter J. Choi, Thomas I. H. Park, William A. Denny, Jiney Jose, Jóhannes Reynisson, Petr Tomek, Moana Tercel, Elizabeth Cooper
Rok vydání: 2022
Předmět:
Zdroj: Molecules; Volume 27; Issue 3; Pages: 880
Molecules, Vol 27, Iss 880, p 880 (2022)
ISSN: 1420-3049
DOI: 10.3390/molecules27030880
Popis: The CDK4/6 inhibitor palbociclib, combined with endocrine therapy, has been shown to be effective in postmenopausal women with estrogen receptor positive, HER2-negative advanced or metastatic breast cancer. However, palbociclib is not as effective in the highly aggressive triple-negative breast cancer that lacks sensitivity to chemotherapy or endocrine therapy. We hypothesized that conjugation of the near-infrared dye MHI-148 with palbociclib can produce a potential theranostic in triple-negative as well as estrogen receptor positive breast cancer cells. In our study, the conjugate was found to have enhanced activity in all mammalian cell lines tested in vitro. However, the conjugate was cytotoxic and did not induce G1 cell cycle arrest in breast cancer cells suggesting the mechanism of action differed from the parent compound palbociclib. The study highlights the importance of investigating the mechanism of conjugates of near-infrared dyes to therapeutic compounds as conjugation can potentially result in a change of mechanism or target, with an enhanced cytotoxic effect in this case.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje